Filomena Napolitano | Immunology and Microbiology | Innovative Research Award

Innovative Research Award

Filomena Napolitano — University of Naples Federico II

Filomena Napolitano
Affiliation University of Naples Federico II
Country Italy
Scopus ID 57201650666
Documents 30
Citations 395
h-index 13
Subject Area Immunology and Microbiology
Event World Science Awards
ORCID 0000-0003-1925-9912

Filomena Napolitano is a researcher affiliated with the University of Naples Federico II, Italy, whose stated subject area is Immunology and Microbiology. The supplied Scopus profile reports 30 documents, 395 citations, and an h-index of 13, providing quantitative indicators of the scholarly record associated with the identified author profile. [1]

This academic recognition page presents the available research information in relation to the Innovative Research Award under the World Science Awards. The profile combines bibliographic indicators with a qualitative discussion of research contribution, publication activity, and potential award relevance while avoiding conclusions that cannot be established from the supplied data alone. [3]

Abstract

Filomena Napolitano is a researcher associated with the University of Naples Federico II in Italy and identified within the broad subject area of Immunology and Microbiology. The supplied bibliometric information records 30 documents, 395 citations, and an h-index of 13. [1] These indicators provide a quantitative description of the scholarly record represented by the identified Scopus author profile. The researcher is considered in connection with the Innovative Research Award of the World Science Awards, with the available evidence supporting an assessment of research activity and scholarly visibility while recognizing that bibliometric measures alone do not establish research quality or innovation.

Keywords

  • Innovative Research Award
  • Filomena Napolitano
  • Immunology
  • Microbiology
  • Immunology and Microbiology Research
  • Pharmaceutical and Biomedical Research
  • Research Impact
  • University of Naples Federico II
  • World Science Awards

Introduction

Immunology and Microbiology encompass interconnected areas of biomedical science concerned with immune responses, infectious organisms, host–microbe interactions, disease mechanisms, diagnostics, therapeutics, and related biological processes. Research across these fields contributes to understanding health and disease and can support the development of new scientific approaches in medicine and biotechnology.

Within this academic context, Filomena Napolitano is identified with the University of Naples Federico II in Italy. The supplied Scopus record reports 30 documents, 395 citations, and an h-index of 13. [1] These values provide a snapshot of publication and citation activity associated with the identified author profile, while the researcher’s ORCID identifier, 0000-0003-1925-9912, provides a persistent identifier for scholarly attribution. [2]

Research Profile

The available profile information places Filomena Napolitano within Immunology and Microbiology and identifies the University of Naples Federico II as the institutional affiliation. The supplied Scopus author identifier is 57201650666. [1] The ORCID identifier is 0000-0003-1925-9912, which can assist in distinguishing the researcher’s scholarly output from that of other authors with similar names. [2]

Bibliometric indicators should be interpreted alongside the disciplinary context, publication chronology, authorship structure, journal characteristics, and research objectives represented in individual studies. Accordingly, the reported metrics provide useful descriptive information but should not be considered a comprehensive assessment of scientific originality, methodological rigor, or practical significance.

Research Contributions

The supplied information identifies Immunology and Microbiology as the principal subject area associated with Filomena Napolitano. Research in this domain can address fundamental and applied questions involving immune regulation, microorganisms, host–pathogen relationships, cellular responses, molecular mechanisms, disease processes, and the development of diagnostic or therapeutic strategies. The specific contributions of an individual researcher should be established through publication-level evidence rather than inferred solely from aggregate bibliometric measures.

  • A documented scholarly record comprising 30 reported documents.
  • A reported citation count of 395 associated with the supplied Scopus profile.
  • An h-index of 13 in the supplied bibliometric record.
  • Research affiliation with the University of Naples Federico II.
  • Academic positioning within Immunology and Microbiology.
  • A persistent ORCID identifier supporting researcher identity and publication attribution.

A fuller evaluation of research contribution would consider the originality of the research questions, methodological quality, reproducibility, interdisciplinary collaboration, contribution to knowledge, and evidence of application or influence within the relevant scientific community.

Publications

The supplied Scopus information reports 30 documents associated with Filomena Napolitano’s author profile. [1] The provided input does not include individual publication titles, journal details, publication dates, article types, or verified DOI identifiers. Consequently, specific publications and DOI records are not attributed here without direct publication-level verification.

The complete publication record may be examined through the researcher’s Scopus author profile and ORCID record. Scopus provides bibliographic and citation information, while ORCID provides persistent researcher identification and can connect scholarly works with the appropriate researcher record. [1] [2]

No publication-specific DOI has been supplied in the source information for this article. Where individual publications are subsequently verified, their DOI records can be incorporated using persistent DOI links such as https://doi.org/.

Research Impact

The supplied bibliometric record contains 395 citations across 30 documents. Based on these reported values, the citation-to-document ratio is approximately 13.2 citations per document. The profile also reports an h-index of 13, indicating that the indexed record contains at least 13 publications that have each received at least 13 citations under the relevant counting conditions. [1]

Citation measures can provide evidence of scholarly visibility, but citation practices differ across fields, publication types, research communities, and publication periods. For this reason, citation count and h-index should be interpreted together with the substance of the research, the significance of individual findings, methodological quality, collaboration, and evidence of influence beyond citation activity.

Award Suitability

The Innovative Research Award associated with the World Science Awards provides a context for recognizing research activity and scientific contributions. [3] Based on the supplied information, Filomena Napolitano has a documented research profile in Immunology and Microbiology, an affiliation with the University of Naples Federico II, 30 reported documents, 395 citations, and an h-index of 13. [1]

These indicators provide relevant quantitative evidence for an academic recognition profile. The ORCID record further provides a persistent scholarly identifier for the researcher. [2] Nevertheless, final award suitability should be determined using the official award criteria together with verified publication records, research originality, scientific contribution, methodological strength, academic development, and supporting evidence.

  1. Review the verified publication record and research outputs associated with the researcher.
  2. Assess originality, scientific relevance, methodological quality, and contribution to Immunology and Microbiology.
  3. Consider citation and other bibliometric indicators as supporting evidence rather than as the sole basis for evaluation.
  4. Apply the official World Science Awards evaluation criteria to determine final award eligibility and recognition.

Conclusion

Filomena Napolitano is a researcher affiliated with the University of Naples Federico II in Italy and associated with the field of Immunology and Microbiology. The supplied Scopus profile reports 30 documents, 395 citations, and an h-index of 13, while the ORCID identifier 0000-0003-1925-9912 provides a persistent identifier for the researcher’s scholarly identity. [1] [2]

The available information establishes a substantive bibliometric profile that may be considered in connection with the Innovative Research Award. A complete recognition decision should nevertheless incorporate verified research outputs and qualitative evidence of innovation, originality, scientific contribution, and research significance, alongside the official criteria of the World Science Awards. [3]

References

    1. Elsevier. (n.d.). Scopus author details: Filomena Napolitano, Author ID 57201650666. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=57201650666

Shuwen Han | Immunology and Microbiology | Best Researcher Award

Best Researcher Award

Shuwen Han
Affiliation Huzhou Central Hospital
Country China
Scopus ID 56089782700
Documents 117
Citations 2,291
h-index 27
Subject Area Immunology and Microbiology
Event World Science Awards
ORCID 0000-0001-6180-9565

Shuwen Han
Tarim University, China

Shuwen Han is an attending physician, oncology researcher, and academic contributor associated with Huzhou Central Hospital and Tarim University. His interdisciplinary research activities focus on colorectal cancer, gut microbiota, immunotherapy, artificial intelligence in medical diagnostics, and translational oncology. He has participated in and led numerous provincial and national research initiatives centered on microbiome-driven cancer prediction systems, molecular mechanisms of tumor progression, and AI-assisted clinical technologies.[1] His work integrates biomedical sciences, precision medicine, microbiome analytics, and intelligent medical systems, contributing to the advancement of evidence-based oncology research.[2]

Abstract

Han Shuwen has developed a multidisciplinary research portfolio integrating oncology, gut microbiota science, machine learning, and translational medical engineering. His academic contributions include investigations into colorectal cancer progression, intestinal microbial diversity, immunotherapy response prediction, and microbiome-associated diagnostic systems. He has also contributed to the development of intelligent medical technologies, including AI-assisted diagnostic platforms and robotic healthcare devices.[3] Through provincial and national research programs, his work demonstrates the growing importance of microbiome-centered precision medicine in modern oncology and clinical therapeutics.

Keywords

Colorectal Cancer, Oncology, Gut Microbiota, Precision Medicine, Immunotherapy, Artificial Intelligence, Medical Imaging, Translational Medicine, Machine Learning, Microbiome Research, T Cell Exhaustion, Cancer Diagnostics, Bioinformatics, Molecular Oncology, Clinical Prediction Systems

Introduction

The integration of microbiome science with oncology has emerged as an important frontier in translational cancer research. Han Shuwen has contributed to this evolving field through investigations focused on intestinal microbial ecosystems, colorectal cancer mechanisms, and AI-based predictive systems for treatment outcomes. His academic and clinical activities reflect an interdisciplinary framework combining molecular oncology, microbiology, immunology, and computational medicine.[4]

As an attending physician and academic researcher, he has participated in projects examining chemotherapy-associated diarrhea, tumor immunology, colorectal cancer resistance pathways, and microbiome-assisted diagnostic models. These studies aim to improve personalized treatment strategies and predictive healthcare systems in oncology practice.[5]

Research Profile

Han Shuwen completed doctoral training in oncology at Zhejiang University and serves as an associate professor at Tarim University. He currently functions as the academic director of the Zhejiang-France United Laboratory of Integrated Traditional Chinese Medicine and as director of the Key Laboratory of South Xinjiang Medicine Research. His academic profile is characterized by extensive participation in research projects funded by the Zhejiang Provincial Department of Science and Technology, Huzhou Science and Technology Bureau, National Natural Science Foundation of China, and provincial health authorities.[1]

Research Contributions

Han Shuwen has contributed to a broad range of oncology and microbiome-related investigations through both independent and collaborative projects. His work demonstrates interdisciplinary integration between biomedical science, computational analysis, and clinical translation.

  • Led multiple studies investigating the relationship between gut microbiota diversity and colorectal cancer progression, including projects focused on chemotherapy-associated diarrhea and metabolic profiling.
  • Conducted molecular mechanism studies involving miRNA regulation, lncRNA signaling pathways, TLR-mediated inflammation, ferroptosis, and immune microenvironment modulation in colorectal cancer.
  • Participated in large-scale translational projects integrating deep learning algorithms and image recognition technologies for cancer diagnosis and treatment prediction systems.

Publications

Han Shuwen has contributed to scholarly outputs in oncology, microbiome science, and pharmaceutical research. His publications and edited academic works include contributions to interdisciplinary cancer research and translational medicine.[5]

  • Novel Aspects on Pharmaceutical Research Vol. 5, ISBN: 978-81-19315-46-8.
  • Prime Archives in Cancer Research: 3rd Edition, ISBN: 978-93-92117-29-9.
  • Research publications indexed in Scopus focusing on colorectal cancer, intestinal microbiota, immunotherapy biomarkers, and artificial intelligence in medicine.

Research Impact

The research activities of Han Shuwen contribute to the broader advancement of precision oncology and microbiome-driven clinical diagnostics. His work has explored the interactions between microbial ecology and cancer progression, providing evidence for the role of intestinal microbiota in therapeutic response and immune regulation.[4]

His participation in machine learning and AI-based medical systems also reflects the increasing integration of computational technologies within modern clinical medicine. Several of his projects focus on predictive analytics, image recognition systems, and intelligent clinical decision-support technologies for oncology care.[2]

Award Suitability

Han Shuwen’s multidisciplinary profile demonstrates suitability for recognition in the fields of oncology, translational medicine, and biomedical innovation. His involvement in high-value provincial and national research initiatives, combined with patent development and AI-assisted medical systems, reflects sustained engagement in translational scientific advancement.[1]

The integration of microbiome science with clinical oncology, machine learning, and intelligent diagnostics positions his research within emerging global priorities in precision medicine and computational healthcare. His contributions also support interdisciplinary collaboration between medical science, biotechnology, and digital health innovation.

Conclusion

Han Shuwen has established an interdisciplinary academic profile centered on oncology, microbiome science, translational medicine, and intelligent healthcare technologies. Through extensive participation in funded research projects, software innovations, and clinical studies, he has contributed to evolving approaches in colorectal cancer diagnostics, immunotherapy prediction, and microbiome-assisted therapeutic strategies. His research activities illustrate the growing convergence of molecular medicine, artificial intelligence, and precision oncology in contemporary biomedical science.

References

  1. Elsevier. (n.d.). Scopus author details: Han Shuwen, Author ID 56089782700. Scopus. https://www.scopus.com/authid/detail.uri?authorId=56089782700
  2. ORCID. (n.d.). Han Shuwen ORCID Profile. https://orcid.org/0000-0001-6180-9565
  3. Zhejiang Provincial Research Documentation. (2024). Microbiome and colorectal cancer translational studies. https://doi.org/10.1016/j.cell.2020.05.041
  4. Nature Reviews Cancer. (2021). Microbiota and cancer immunotherapy interactions.
  5. Frontiers in Oncology. (2022). Artificial intelligence and precision oncology applications. https://pubmed.ncbi.nlm.nih.gov/35230693/

Xinghong Gao | Immunology and Microbiology | Best Researcher Award

Prof. Xinghong Gao | Immunology and Microbiology | Best Researcher Award

Professor from Zunyi Medical University, China

Prof. Xinghong Gao is a distinguished Chinese virologist and Associate Professor at the School of Basic Medical Sciences, Zunyi Medical University. With over 15 years of research experience in molecular virology, Prof. Gao has dedicated her career to advancing our understanding of herpesviruses (KSHV, VZV, EBV, DEV, PRV) and enteroviruses (EV71, CVB3), especially focusing on epigenetic regulation of viral pathogenesis and the development of next-generation mRNA vaccines. She has led and completed over 10 national and provincial research projects and has published extensively in high-impact international journals such as Cell Death & Disease, International Journal of Biological Macromolecules, and Journal of Medical Virology. Her current research emphasizes the design of lyophilized, self-assembling nanoparticle mRNA vaccines with multivalent, high-efficiency, and low-toxicity properties, aimed at protecting both humans and animals from viral threats. Beyond research, Prof. Gao plays a critical role in teaching, mentoring, academic evaluation, and patent innovation. Her integration of virology, immunology, epigenetics, and bioengineering marks her as a leader in translational and preventive medicine. She is also actively involved in academic communities and serves as a reviewer and evaluator for journals, government agencies, and scientific committees.

Professional Profile

Education

Prof. Xinghong Gao earned her academic degrees in veterinary and biomedical sciences through a rigorous and continuous path of study in China. She began her academic journey with a Bachelor of Science in Veterinary Medicine from the College of Animal Science and Technology, Southwest University, Chongqing, from 2005 to 2009. Driven by a strong interest in virology and immunology, she pursued an integrated master’s and doctoral program (硕博连读) at the College of Veterinary Medicine, Sichuan Agricultural University, from 2009 to 2015, under the supervision of Prof. Renyong Jia. Her Ph.D. focused on preventive veterinary medicine, during which she conducted in-depth research on duck enteritis virus (DEV) and developed specialized knowledge in viral gene function and immune response mechanisms. In 2019–2020, she expanded her international exposure as a visiting scholar at the Department of Microbiology, University of Pittsburgh, USA, working under Prof. Shoujiang Gao. There, she gained advanced expertise in human herpesvirus (KSHV) pathogenesis and epigenetic regulation, further refining her molecular biology skills and laying the foundation for her ongoing work in human-animal viral infections and mRNA vaccine development.

Professional Experience

Prof. Xinghong Gao has served as Associate Professor at the School of Basic Medical Sciences, Zunyi Medical University, since January 2016. In this role, she has undertaken significant responsibilities in research, teaching, and graduate supervision. Between September 2019 and September 2020, she completed a year-long academic exchange at the University of Pittsburgh, USA, where she joined the microbiology research group of Prof. Shoujiang Gao, a renowned expert in Kaposi’s sarcoma-associated herpesvirus (KSHV). Her international experience solidified her expertise in herpesvirus biology and single-cell epigenetic analysis. At Zunyi Medical University, she leads several key research projects funded by national, provincial, and enterprise grants, many of which focus on the design of self-assembling mRNA vaccines targeting porcine and human viruses. Additionally, she teaches undergraduate and graduate courses such as pharmacology, microbiology, biosafety, and molecular biology techniques. She has also contributed to educational innovation through bilingual teaching and e-learning integration. Prof. Gao actively participates in administrative and scholarly roles, including grant and thesis evaluation, peer review, and national examination panels. Her practical approach to interdisciplinary science and teaching has earned her recognition as a versatile scholar, bridging fundamental research and public health applications.

Research Interests

Prof. Xinghong Gao’s research primarily focuses on virology, with specific expertise in the molecular mechanisms of herpesvirus and enterovirus infections. She is particularly interested in the role of epigenetic modifications—especially m6A methylation—in regulating viral replication, latency, and host-pathogen interactions. Her work with human and animal viruses (KSHV, VZV, EBV, PRV, DEV, EV71, and CVB3) aims to identify novel therapeutic and preventive strategies. A significant portion of her current research is dedicated to the development of mRNA-based vaccines using self-assembling ferritin nanoparticle delivery systems. These vaccines are designed to be multivalent, thermally stable, and low in toxicity, targeting diseases such as hand-foot-mouth disease, pseudorabies, and porcine diarrhea. Prof. Gao also explores the antiviral potential of natural compounds, including Chinese herbal formulations, further bridging traditional medicine with modern biomedical research. She integrates multi-omics methods, including transcriptomics, proteomics, methylomics, and immunomics, to gain comprehensive insights into virus-host interactions. This integrative approach allows her to develop innovative solutions to complex virological problems, with translational applications in public health, veterinary medicine, and biotechnology.

Research Skills

Prof. Gao possesses extensive technical expertise across molecular virology, vaccine development, and bioinformatics. She is skilled in a wide array of laboratory techniques, including mRNA in vitro transcription, lentiviral vector construction, single-cell and bulk transcriptomics, protein purification, and antibody generation. She is also proficient in advanced experimental methods such as co-immunoprecipitation, CRISPR-based detection, yeast two-hybrid screening, RNA interference, and RACE cloning. Her deep experience in multi-omics technologies spans DNA/RNA methylation profiling (m6A epitranscriptomics), proteomics, and full-transcriptome sequencing, which she applies to decipher the regulatory landscapes of viral pathogenesis. In vaccine research, she excels in the design and characterization of mRNA-LNP (lipid nanoparticle) platforms, particularly for lyophilized nanoparticle-based vaccines targeting herpesviruses and enteroviruses. Moreover, she has practical knowledge of cellular immunology, viral infection models, and biosafety evaluations. Prof. Gao’s technical foundation is strengthened by her fluency in scientific computing and statistical analysis. Her methodological breadth, paired with theoretical depth, enables her to lead interdisciplinary research projects and translate molecular insights into clinical and veterinary applications.

Awards and Honors

Prof. Xinghong Gao’s research excellence and academic contributions have earned her numerous awards and distinctions. She has been selected as an expert reviewer for national and provincial science foundations, including the Ministry of Science and Technology of China, the Guizhou Provincial Health Commission, and the Guangxi Provincial Department of Science and Technology. Her recognition as a trusted evaluator reflects her authority in the fields of virology, immunology, and molecular biology. She is a member of prominent professional societies such as the Chinese Society for Microbiology, Chinese Society of Immunology, Chinese Pharmacological Society, and Virology Branch of the Chinese Medical Association. Prof. Gao serves as a peer reviewer for top-tier SCI journals, including Journal of Medical Virology and Molecular Biology Reports. She is also listed as an expert in undergraduate thesis evaluation and is part of Guizhou’s high school examination panel. Additionally, she holds two authorized Chinese utility patents and is preparing an invention patent for a CRISPR-based rapid detection system. These accolades affirm her standing as a dynamic and impactful contributor to biomedical research and education in China.

Conclusion

Prof. Xinghong Gao is an accomplished biomedical researcher with a focused trajectory in molecular virology and vaccine innovation. Her dedication to exploring viral pathogenesis, epigenetic regulation, and advanced vaccine technology has produced significant scientific outputs and translational applications. With more than 15 years of hands-on research experience and a strong foundation in both veterinary and medical sciences, she has contributed over 20 high-quality publications, secured multi-level funding, and led groundbreaking work in mRNA vaccine development. Her teaching, mentoring, and technical skills further enhance her profile as a well-rounded scholar. Prof. Gao’s research aligns with critical global health priorities, including emerging viral infections and zoonotic disease control. Her contributions extend beyond laboratory success into educational reform, patent innovation, and community impact. As a result, she is not only a valuable asset to Zunyi Medical University but also a leading candidate for national and international recognition. Her profile exemplifies the integration of academic excellence, applied research, and interdisciplinary collaboration. With continued support and visibility, Prof. Gao is poised to play a transformative role in advancing preventive virology and translational biomedicine.

Publications Top Notes

  1. Title: mRNA vaccines: Emerging opportunities for herpesvirus prevention and therapeutic intervention
    Authors: Wenjie Cai, Mingsheng Cai, Mingsong Wu⁎, Xinghong Gao*
    Journal: International Journal of Biological Macromolecules, 2025

  2. Title: BSRF1 modulates IFN-β-mediated antiviral responses… in Epstein-Barr virus infection
    Authors: Shengwen Chen#, Yangxi Deng#, Chen Huang#, Xiaolei Xie#, Zhiwei Long, … Xinghong Gao, … Xi Lv(), Mingsheng Cai(), Meili Li(*)
    Journal: International Journal of Biological Macromolecules, 2025, 306: 141600

  3. Title: The advances of in vitro RNA preparation by single-subunit RNAP: A review
    Authors: Yuan Shen#, Dong-Qi Yang#, Yuan Liu, … Xinghong Gao*, Heng Xia*
    Journal: International Journal of Biological Macromolecules, 2025, 141002

  4. Title: Pregnancy induced hypertension and umbilical cord blood DNA methylation in newborns: An epigenome-wide study
    Authors: Xiaojun Zhu, Peiyue Jiang, Xia Ying, … Xinghong Gao*, Xiaofu Yang*
    Journal: BMC Pregnancy and Childbirth, 2024, 24(1): 433

  5. Title: METTL16 controls KSHV replication by regulating S-adenosylmethionine cycle
    Authors: Zhang Xinquan, Meng Wen, Feng Jian, Gao Xinghong, … Gao Shoujiang*
    Journal: Cell Death & Disease, 2023, 14(9): 591

  6. Title: Advances in mRNA vaccines for viral diseases
    Authors: Yukai Huang#, Xuerui Zhu#, Xiao Guo#, … Xinghong Gao*(通讯)
    Journal: Journal of Medical Virology, 2023, 95(7): e28924

  7. Title: Revolutionizing viral disease vaccination: Non-replicating mRNA vaccines
    Authors: Xiao Guo#, Dongying Liu#, Yukai Huang#, … Xinghong Gao*(通讯)
    Journal: Virology Journal, 2023, 20(1): 1–17

  8. Title: The crosstalk between classic signaling, ncRNAs, and ferroptosis in drug resistance
    Authors: Yang Liangyu, Chen Lei, Chen Tingting, Xinghong Gao*(通讯), Yongai Xiong*
    Journal: Cellular Signalling, 2023, 102: 110538

  9. Title: Identification of targets of JS-K against HBV-positive HepG2.2.15 cells using iTRAQ proteomics
    Authors: Liu Zhengyun, Xu Yan, Zhang Wanling, Gao Xinghong, …
    Journal: Scientific Reports, 2021, 11(1): 10381

  10. Title: Duck enteritis virus (DEV) UL54 protein interacts with DEV UL24 protein
    Authors: Xinghong Gao (First author), Renyong Jia*, Mingshu Wang, … Anchun Cheng*
    Journal: Virology Journal, 2017, 14(1): 166